Literature DB >> 11292920

Experience with fatal interstitial pneumonia after operation for lung cancer.

T Tanita1, M Chida, Y Hoshikawa, M Handa, M Sato, M Sagawa, S Ono, Y Matsumura, T Kondo, S Fujimura.   

Abstract

BACKGROUND: The number of patients with lung cancer is increasing. This study was undertaken to realize the probability, fate and management of acute fatal postoperative complications. Since interstitial pneumonia was one of the most fatal postoperative complications, to know its incidence and fate is very important.
METHODS: A total of 2667 patients who underwent thoracotomy caused by malignant tumors during the past 17 years were reviewed and studied. We performed investigations on medical records, chest X-rays, whole-body CT films, operative records and pathological specimens for all inpatients.
RESULTS: Nineteen patients died in hospital 30 days after thoracotomy (operative death). Nine patients died in hospital more than 31 days after thoracotomy (hospital death). Eight cases out of 28 patients (operative and hospital deaths) developed and finally died by interstitial pneumonia. Each case was treated with steroids, neutrophil-elastase inhibitor, and/or immunosuppressive agents. These patients could not be selected by any preoperative laboratory examination, such as preoperative pulmonary function tests, serum biochemistry tests, and chest X-ray or CT films. Interstitial pneumonia as a complication of postoperative stage, was fatal and once developed, it was very difficult to save their lives.
CONCLUSIONS: Since we reported the cases who died from acute postoperative complications, especially interstitial pneumonia, we could not present effective management. However, in this report, several therapeutic trials that may solve the problems of acute postoperative interstitial pneumonia were proposed.

Entities:  

Mesh:

Year:  2001        PMID: 11292920

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  6 in total

1.  Postoperative pyothorax a risk factor for acute exacerbation of idiopathic interstitial pneumonia following lung cancer resection.

Authors:  Satoru Kobayashi; Yoko Karube; Morimichi Nishihira; Takashi Inoue; Osamu Araki; Sumiko Maeda; Tetsu Sado; Yuji Matsumura; Masayuki Chida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-06-08

2.  The surgical outcomes of lung cancer combined with interstitial pneumonia: a single-institution report.

Authors:  Daisuke Taniguchi; Naoya Yamasaki; Takuro Miyazaki; Tomoshi Tsuchiya; Keitaro Matsumoto; Go Hatachi; Tomoyuki Kakugawa; Noriho Sakamoto; Hiroshi Mukae; Takeshi Nagayasu
Journal:  Surg Today       Date:  2017-06-06       Impact factor: 2.549

3.  Clinical impact of concomitant surgical diagnosis and subsequent lobectomy for preoperatively undiagnosed lung cancer.

Authors:  Shin-ichi Takeda; Masaru Koma; Yoshihisa Kadota; Yasunobu Funakoshi; Takashi Kusu; Hajime Maeda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-05

4.  Inflammation-Based Prognostic Score Predicts Postoperative Survival of Patients with Interstitial Pneumonia After Undergoing Lung Cancer Resection.

Authors:  Satoru Kobayashi; Yuji Matsumura; Yoko Karube; Morimichi Nishihira; Takashi Inoue; Osamu Araki; Sumiko Maeda; Masayuki Chida
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

5.  Serum Carcinoembryonic Antigen Level Predicts Cancer-Specific Outcomes of Resected Non-Small Cell Lung Cancer With Interstitial Pneumonia.

Authors:  Masaki Tomita; Takanori Ayabe; Ryo Maeda; Kunihide Nakamura
Journal:  World J Oncol       Date:  2018-11-23

Review 6.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.